Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
about
The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activityInteraction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finRole of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.Organization of the human alpha 2-plasmin inhibitor geneMolecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.Molecular cloning of a serine proteinase inhibitor from Brugia malayiStructural insights into the unique inhibitory mechanism of the silkworm protease inhibitor serpin18.Serpins in thrombosis, hemostasis and fibrinolysisBiophysical Mechanisms Mediating Fibrin Fiber Lysis.Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.Role of residue Y99 in tissue plasminogen activator.An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin.Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.Different N-terminal forms of alpha 2-plasmin inhibitor in human plasmaLipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages.
P2860
Q24298078-CE6B4105-2E90-4831-A9A0-8F2DD476D26BQ24300911-2CA57AB7-7EF2-45B9-AB34-54E48A02B67DQ33177672-163A8BE8-E020-4638-A95E-C8DCCED198ADQ33648214-C74DC1EB-3C9D-4BF3-AE36-E21EC08D0580Q34572566-1175A20C-C826-40E2-852D-B799577C5F70Q35367680-BBCD2EB9-7DDD-4A15-BF89-36046D09C9ABQ35408717-B66A5FC9-F128-4CAF-9975-B353B43F7BA7Q35824673-FF008E2C-9BAB-44D9-A758-9FB758F90FF1Q36884340-FC230456-9950-4100-B9EF-A69C7680C422Q38669149-A6AFC71C-70B2-4F09-BED0-B9BD7F45F01AQ41822745-68506718-B511-4B08-9822-AA100761A4AEQ41952017-61CB6265-CF66-4787-994A-5143BA4FE61CQ42124189-803E820E-6350-48E7-AB00-215E76EF7A70Q42127015-060A9FE6-2CA6-4A91-AD50-ADAEF2C7C40CQ42797227-ECCBDB8C-B324-4CFF-AD41-0AE22EE8463FQ42938869-9B8A0D5A-DB7F-4743-8EDB-F21C187F77EB
P2860
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
description
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1987
@ast
im Februar 1987 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1987/02/05)
@sk
vědecký článek publikovaný v roce 1987
@cs
wetenschappelijk artikel (gepubliceerd op 1987/02/05)
@nl
наукова стаття, опублікована в лютому 1987
@uk
name
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@ast
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@en
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@nl
type
label
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@ast
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@en
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@nl
prefLabel
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@ast
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@en
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@nl
P2093
P1476
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)
@en
P2093
H. R. Lijnen
W. E. Holmes
P304
P407
P577
1987-02-05T00:00:00Z